RankAlpha logo
Back to Rankings

BEAM

Beam TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
BEAM vs peer average
64/100
BEAM vs. peer average (B vs. C)
Grade spread
A 3 · B 1 · D 2 · F 2
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

LQDA is the first available peer comparator.

Liquidia is another loose SMID-cap biotech comparator where valuation is milestone- and regulatory-timing driven, which makes it useful for sentiment framing but not for direct platform comparability.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerLQDALiquidia
BEAM
Beam Therapeutics
LQDA
Liquidia
Grade
B
A
Momentum
76
97
Value
41
41
Sentiment
66
49
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs LQDA

BEAM / LQDA
Grade Position
In line
BEAM vs. peer average (B vs. C)
64/100
Momentum
76
LQDA
Value
41
BEAM
Sentiment
66
BEAM

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BEAM
1
LQDA
LQDA
A
100/100
-1
2
RCUS
RCUS
B
80/100
Even
3
DNLI
Denali Therapeutics Inc Common
A
100/100
-1
4
TLX
Telix Pharmaceuticals Ltd ADR
N/A
-
-
5
ORKA
Oruka Therapeutics Inc Common
D
40/100
+2
LQDA is the first peer returned for this comparison set.